SL Radar November 2025

The current BAG file shows broad price pressure in the list of specialties: across all clusters, the median FAP reduction is around 9-10%, with an upper decile of ≥ approx. 20% and peak values of over 40%. Standard cardiovascular therapies and selected anti-infectives are particularly affected, while individual high-cost specialties are seeing moderate but noticeable reductions.

Most strategically important price reductions:

• Lercanidipine generics and Zanidip: For lercanidipine generics (Sandoz, Axapharm, Spirig HC, Zentiva, Mepha), the median FAP discounts are around 40%; the original Zanidip is reduced by around 26-27%. The packs are inexpensive individually, but are among the high-volume antihypertensive drugs.
• Co-irbesartan and olmesartan/amlodipine generics: Co-irbesartan generics and olmesartan/amlodipine combinations are seeing median FAP reductions in the range of approximately 25-29%. As broad standard therapies in the treatment of hypertension, these double-digit discounts are generating significant relief in the segment.
• Maviret and Zavicefta: Maviret and Zavicefta have moderate FAP discounts of around 9-11%, but with very high starting prices and a pricing model in each case. This enables the FOPH to achieve a double dampening effect for curative high-cost anti-infectives: visible list price reductions plus additional, non-transparent net savings via the pricing model.

What does this mean for the future?

The latest BAG file highlights that generic drugs and standard comparators are being consistently pushed downwards, while high-cost specialties are being addressed through a combination of pricing models and FAP reductions. In the coming months, antihypertensives and anti-infectives, pricing model adjustments, and additional cases with a 40% co-payment and GGSL focus should be closely monitored.

bonus

If, after studying the figures, you still have the energy for further SL innovations, we recommend taking a look at the new Wegovy limitation: with a total of around 80 lines of limitation text, it sets a new negative record in terms of length and depth of detail.